A Randomised Trial of Paclitaxel (Taxol) in Combination with Platinum Chemotherapy versus Conventional Platinum-Based Chemotherapy in the Treatment of Women with Relapsed Ovarian Cancer.
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Cisplatin
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms ICON-4
- 08 Dec 2015 Accrual to date is 8%, according to United Kingdom Clinical Research Network record.
- 03 Jul 2009 Additional lead trial investigator (Amos C) identified as reported by ClinicalTrials.gov.
- 03 Jul 2009 New source identified and integrated (ISRCTN: Current Controlled Trials).